Skip to main content
PMC home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1986 Feb;83(4):1016–1020. doi: 10.1073/pnas.83.4.1016

Genetic analysis of the fragile-X mental retardation syndrome with two flanking polymorphic DNA markers.

I Oberlé, R Heilig, J P Moisan, C Kloepfer, G M Mattéi, J F Mattéi, J Boué, U Froster-Iskenius, P A Jacobs, G M Lathrop, et al.
PMCID: PMC323001  PMID: 3006023

Abstract

The fragile-X mental retardation syndrome, one of the most prevalent chromosome X-linked diseases (approximately equal to 1 of 2000 newborn males), is characterized by the presence in affected males and in a portion of carrier females of a fragile site at chromosomes band Xq27. We have performed a linkage analysis in 16 families between the locus for the fragile-X syndrome, FRAXQ27, and two polymorphic DNA markers that correspond to the anonymous probe St14 and to the coagulation factor IX gene F9. Our results indicate that the order of loci is centromere-F9-FRAXQ27-St14-Xqter. The estimate of the recombination fraction for the linkage F9-FRAXQ27 is 0.12 (90% confidence limits: 0.044-0.225) and 0.10 for FRAXQ27-St14 (90% confidence limits: 0.040-0.185). Recombination between St14 and F9 does not appear to be significantly different in normal and fragile-X families. The two flanking probes were used for diagnosis of the carrier state and for detection of transmission of the disease through phenotypically normal males. They should also allow first-trimester diagnosis with a reliability of about 98% in 40% of the families. Used in conjunction with the cytogenetic analysis, the segregation studies with both probes should improve the genetic counseling for the fragile-X syndrome and should be useful for the formal genetic analysis of this unique disease.

Full text

PDF
1016

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alwine J. C., Kemp D. J., Parker B. A., Reiser J., Renart J., Stark G. R., Wahl G. M. Detection of specific RNAs or specific fragments of DNA by fractionation in gels and transfer to diazobenzyloxymethyl paper. Methods Enzymol. 1979;68:220–242. doi: 10.1016/0076-6879(79)68017-5. [DOI] [PubMed] [Google Scholar]
  2. Brown W. T., Gross A. C., Chan C. B., Jenkins E. C. Genetic linkage heterogeneity in the fragile X syndrome. Hum Genet. 1985;71(1):11–18. doi: 10.1007/BF00295659. [DOI] [PubMed] [Google Scholar]
  3. Camerino G., Grzeschik K. H., Jaye M., De La Salle H., Tolstoshev P., Lecocq J. P., Heilig R., Mandel J. L. Regional localization on the human X chromosome and polymorphism of the coagulation factor IX gene (hemophilia B locus). Proc Natl Acad Sci U S A. 1984 Jan;81(2):498–502. doi: 10.1073/pnas.81.2.498. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Camerino G., Mattei M. G., Mattei J. F., Jaye M., Mandel J. L. Close linkage of fragile X-mental retardation syndrome to haemophilia B and transmission through a normal male. Nature. 1983 Dec 15;306(5944):701–704. doi: 10.1038/306701a0. [DOI] [PubMed] [Google Scholar]
  5. Choo K. H., George D., Filby G., Halliday J. L., Leversha M., Webb G., Danks D. M. Linkage analysis of X-linked mental retardation with and without fragile-X using factor IX gene probe. Lancet. 1984 Aug 11;2(8398):349–349. doi: 10.1016/s0140-6736(84)92715-6. [DOI] [PubMed] [Google Scholar]
  6. Drayna D., Davies K., Hartley D., Mandel J. L., Camerino G., Williamson R., White R. Genetic mapping of the human X chromosome by using restriction fragment length polymorphisms. Proc Natl Acad Sci U S A. 1984 May;81(9):2836–2839. doi: 10.1073/pnas.81.9.2836. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Fishburn J., Turner G., Daniel A., Brookwell R. The diagnosis and frequency of X-linked conditions in a cohort of moderately retarded males with affected brothers. Am J Med Genet. 1983 Apr;14(4):713–724. doi: 10.1002/ajmg.1320140413. [DOI] [PubMed] [Google Scholar]
  8. Froster-Iskenius U., Schulze A., Schwinger E. Transmission of the marker X syndrome trait by unaffected males: conclusions from studies of large families. Hum Genet. 1984;67(4):419–427. doi: 10.1007/BF00291403. [DOI] [PubMed] [Google Scholar]
  9. Fryns J. P. The fragile X syndrome. A study of 83 families. Clin Genet. 1984 Dec;26(6):497–528. doi: 10.1111/j.1399-0004.1984.tb01099.x. [DOI] [PubMed] [Google Scholar]
  10. Grunebaum L., Cazenave J. P., Camerino G., Kloepfer C., Mandel J. L., Tolstoshev P., Jaye M., De la Salle H., Lecocq J. P. Carrier detection of Hemophilia B by using a restriction site polymorphism associated with the coagulation Factor IX gene. J Clin Invest. 1984 May;73(5):1491–1495. doi: 10.1172/JCI111354. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Gusella J. F., Wexler N. S., Conneally P. M., Naylor S. L., Anderson M. A., Tanzi R. E., Watkins P. C., Ottina K., Wallace M. R., Sakaguchi A. Y. A polymorphic DNA marker genetically linked to Huntington's disease. Nature. 1983 Nov 17;306(5940):234–238. doi: 10.1038/306234a0. [DOI] [PubMed] [Google Scholar]
  12. Jacobs P. A., Glover T. W., Mayer M., Fox P., Gerrard J. W., Dunn H. G., Herbst D. S. X-linked mental retardation: a study of 7 families. Am J Med Genet. 1980;7(4):471–489. doi: 10.1002/ajmg.1320070408. [DOI] [PubMed] [Google Scholar]
  13. Jenkins E. C., Brown W. T., Duncan C. J., Brooks J., Ben-Yishay M., Giordano F. M., Nitowsky H. M. Feasibility of fragile X chromosome prenatal diagnosis demonstrated. Lancet. 1981 Dec 5;2(8258):1292–1292. doi: 10.1016/s0140-6736(81)91531-2. [DOI] [PubMed] [Google Scholar]
  14. Lathrop G. M., Lalouel J. M. Easy calculations of lod scores and genetic risks on small computers. Am J Hum Genet. 1984 Mar;36(2):460–465. [PMC free article] [PubMed] [Google Scholar]
  15. Lathrop G. M., Lalouel J. M., Julier C., Ott J. Strategies for multilocus linkage analysis in humans. Proc Natl Acad Sci U S A. 1984 Jun;81(11):3443–3446. doi: 10.1073/pnas.81.11.3443. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Mattei J. F., Mattei M. G., Auger M., Giraud F. Le retard mental lié à la fragilité du chromosome X: connaissances actuelles. J Genet Hum. 1984 Jul;32(3):167–192. [PubMed] [Google Scholar]
  17. Mattei M. G., Baeteman M. A., Heilig R., Oberlé I., Davies K., Mandel J. L., Mattei J. F. Localization by in situ hybridization of the coagulation factor IX gene and of two polymorphic DNA probes with respect to the fragile X site. Hum Genet. 1985;69(4):327–331. doi: 10.1007/BF00291650. [DOI] [PubMed] [Google Scholar]
  18. Mattei M. G., Mattei J. F., Vidal I., Giraud F. Expression in lymphocyte and fibroblast culture of the fragile X chromosome: a new technical approach. Hum Genet. 1981;59(2):166–169. doi: 10.1007/BF00293069. [DOI] [PubMed] [Google Scholar]
  19. Morton N. E. Analysis of crossingover in man. Cytogenet Cell Genet. 1978;22(1-6):15–36. doi: 10.1159/000130916. [DOI] [PubMed] [Google Scholar]
  20. Oberlé I., Drayna D., Camerino G., White R., Mandel J. L. The telomeric region of the human X chromosome long arm: presence of a highly polymorphic DNA marker and analysis of recombination frequency. Proc Natl Acad Sci U S A. 1985 May;82(9):2824–2828. doi: 10.1073/pnas.82.9.2824. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Rhoads F. A., Oglesby A. C., Mayer M., Jacobs P. A. Marker X syndrome in an oriental family with probable transmission by a normal male. Am J Med Genet. 1982 Jun;12(2):205–217. doi: 10.1002/ajmg.1320120211. [DOI] [PubMed] [Google Scholar]
  22. Sherman S. L., Jacobs P. A., Morton N. E., Froster-Iskenius U., Howard-Peebles P. N., Nielsen K. B., Partington M. W., Sutherland G. R., Turner G., Watson M. Further segregation analysis of the fragile X syndrome with special reference to transmitting males. Hum Genet. 1985;69(4):289–299. doi: 10.1007/BF00291644. [DOI] [PubMed] [Google Scholar]
  23. Sherman S. L., Morton N. E., Jacobs P. A., Turner G. The marker (X) syndrome: a cytogenetic and genetic analysis. Ann Hum Genet. 1984 Jan;48(Pt 1):21–37. doi: 10.1111/j.1469-1809.1984.tb00830.x. [DOI] [PubMed] [Google Scholar]
  24. Szabo P., Purrello M., Rocchi M., Archidiacono N., Alhadeff B., Filippi G., Toniolo D., Martini G., Luzzatto L., Siniscalco M. Cytological mapping of the human glucose-6-phosphate dehydrogenase gene distal to the fragile-X site suggests a high rate of meiotic recombination across this site. Proc Natl Acad Sci U S A. 1984 Dec;81(24):7855–7859. doi: 10.1073/pnas.81.24.7855. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Tommerup N., Søndergaard F., Tønnesen T., Kristensen M., Arveiler B., Schinzel A. First trimester prenatal diagnosis of a male fetus with fragile X. Lancet. 1985 Apr 13;1(8433):870–870. doi: 10.1016/s0140-6736(85)92227-5. [DOI] [PubMed] [Google Scholar]
  26. Turner G., Jacobs P. Marker (X)-linked mental retardation. Adv Hum Genet. 1983;13:83–112. doi: 10.1007/978-1-4615-8342-4_2. [DOI] [PubMed] [Google Scholar]
  27. Tønnesen T., Søndergaard F., Güttler F., Oberlé I., Moisan J. P., Mandel J. L., Hauge M., Damsgård E. M. Exclusion of haemophilia B in male fetus by chorionic villus biopsy. Lancet. 1984 Oct 20;2(8408):932–932. doi: 10.1016/s0140-6736(84)90690-1. [DOI] [PubMed] [Google Scholar]
  28. Winship P. R., Anson D. S., Rizza C. R., Brownlee G. G. Carrier detection in haemophilia B using two further intragenic restriction fragment length polymorphisms. Nucleic Acids Res. 1984 Dec 11;12(23):8861–8872. doi: 10.1093/nar/12.23.8861. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES